The decrease in CLA2 levels was similar to that reported in a previous study in patients with rheumatoid arthritis (5), and the cecal abundance of CLA2 tended to decrease with arthritis severity, indicating that CLA2 may be a potential biomarker. This evidence concerns the gene ATP2B3 and rheumatoid arthritis.